levamisole has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chabot, J; Ishak, KG; Lefkowitch, J; Marvin, MR | 1 |
| Asavanich, C; Chearanai, O; Plengvanit, U; Rungpitarangsi, B; Viranuvatti, V; Yongchaiyud, U | 1 |
2 other study(ies) available for levamisole and Bile Duct Cancer
| Article | Year |
|---|---|
Long-term survival of a young woman with peripheral cholangiocarcinoma: a case report.
Topics: Adult; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Disease-Free Survival; Female; Fluorouracil; Hepatectomy; Humans; Levamisole; Time Factors | 1999 |
Immunotherapy of primary liver cancer. A control study of 51 patients.
Topics: Adenoma, Bile Duct; Adult; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Female; Humans; Levamisole; Liver Neoplasms; Male; Middle Aged | 1986 |